152 related articles for article (PubMed ID: 34553368)
1. Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
Huang W; Sundquist K; Sundquist J; Ji J
Br J Haematol; 2022 Feb; 196(3):690-699. PubMed ID: 34553368
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort.
Choi HG; Zehnder JL; Lee YK; Lim H; Kim M
BMC Cancer; 2019 Nov; 19(1):1148. PubMed ID: 31775678
[TBL] [Abstract][Full Text] [Related]
3. Female reproductive factors and risk of lymphoid neoplasm: The Japan Public Health Center-based Prospective Study.
Tanaka S; Sawada N; Yamaji T; Shimazu T; Goto A; Iwasaki M; Inoue M; Tsugane S;
Cancer Sci; 2019 Apr; 110(4):1442-1452. PubMed ID: 30719848
[TBL] [Abstract][Full Text] [Related]
4. Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Dixon BS; Beck GJ; Vazquez MA; Greenberg A; Delmez JA; Allon M; Dember LM; Himmelfarb J; Gassman JJ; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Fenves AZ; Kaufman JS; Cotton JR; Martin KJ; McNeil JW; Rahman A; Lawson JH; Whiting JF; Hu B; Meyers CM; Kusek JW; Feldman HI;
N Engl J Med; 2009 May; 360(21):2191-201. PubMed ID: 19458364
[TBL] [Abstract][Full Text] [Related]
5. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW;
N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638
[TBL] [Abstract][Full Text] [Related]
8. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Regular Use of Low-Dose Aspirin and Neovascular Age-Related Macular Degeneration: National Sample Cohort 2010-2015.
Rim TH; Yoo TK; Kwak J; Lee JS; Kim SH; Kim DW; Kim SS
Ophthalmology; 2019 Feb; 126(2):274-282. PubMed ID: 30240791
[TBL] [Abstract][Full Text] [Related]
10. Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study.
Wyss K; Granath F; Wångdahl A; Djärv T; Fored M; Naucler P; Färnert A
BMC Med; 2020 Oct; 18(1):296. PubMed ID: 33121475
[TBL] [Abstract][Full Text] [Related]
11. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA
Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
14. Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin.
Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A;
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):437-9. PubMed ID: 19289481
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
16. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
Crown N; Mysak T
Am J Health Syst Pharm; 2010 May; 67(9):728-33. PubMed ID: 20410547
[TBL] [Abstract][Full Text] [Related]
17. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
18. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
[TBL] [Abstract][Full Text] [Related]
19. Prevention with low-dose aspirin plus dipyridamole in patients with disabling stroke.
Dippel DW; Maasland L; Halkes P; Kappelle LJ; Koudstaal PJ; Algra A;
Stroke; 2010 Nov; 41(11):2684-6. PubMed ID: 20884870
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Christiansen CB; Pallisgaard J; Gerds TA; Olesen JB; Jørgensen ME; Numé AK; Carlson N; Kristensen SL; Gislason G; Torp-Pedersen C
BMC Neurol; 2015 Nov; 15():225. PubMed ID: 26525411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
